Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.
In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
Global Human Rabies Immunoglobulin (IM) key players include CSL Behring, Grifols, Sanofi, etc. Global top three manufacturers hold a share about 60%.
North America is the largest market, with a share over 30%, followed by China and Europe, both have a share about 45 percent.
In terms of product, HRIG is the largest segment, with a share over 85%. And in terms of application, the largest application is Category III Exposure, followed by Category II Exposure.
The global Human Rabies Immunoglobulin (IM) market was valued at US$ 362 million in 2020 and is expected to reach US$ 568.1 million by the end of 2029, growing at a CAGR of 6.2% during 2021-2029.
This report focuses on Human Rabies Immunoglobulin (IM) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Human Rabies Immunoglobulin (IM) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Human Rabies Immunoglobulin (IM) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
ERIG
HRIG
Segment by Application
Category II Exposure
Category III Exposure
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
1 Human Rabies Immunoglobulin (IM) Market Overview
1.1 Product Overview and Scope of Human Rabies Immunoglobulin (IM)
1.2 Human Rabies Immunoglobulin (IM) Segment by Type
1.2.1 Global Human Rabies Immunoglobulin (IM) Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 ERIG
1.2.3 HRIG
1.3 Human Rabies Immunoglobulin (IM) Segment by Application
1.3.1 Global Human Rabies Immunoglobulin (IM) Sales Comparison by Application: (2021-2029)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Human Rabies Immunoglobulin (IM) Market Size Estimates and Forecasts
1.4.1 Global Human Rabies Immunoglobulin (IM) Revenue 2016-2029
1.4.2 Global Human Rabies Immunoglobulin (IM) Sales 2016-2029
1.4.3 Human Rabies Immunoglobulin (IM) Market Size by Region: 2016 Versus 2021 Versus 2029
2 Human Rabies Immunoglobulin (IM) Market Competition by Manufacturers
2.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Rabies Immunoglobulin (IM) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Rabies Immunoglobulin (IM) Manufacturing Sites, Area Served, Product Type
2.5 Human Rabies Immunoglobulin (IM) Market Competitive Situation and Trends
2.5.1 Human Rabies Immunoglobulin (IM) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Rabies Immunoglobulin (IM) Players Market Share by Revenue
2.5.3 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Rabies Immunoglobulin (IM) Retrospective Market Scenario by Region
3.1 Global Human Rabies Immunoglobulin (IM) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Human Rabies Immunoglobulin (IM) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
3.3.1 North America Human Rabies Immunoglobulin (IM) Sales by Country
3.3.2 North America Human Rabies Immunoglobulin (IM) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
3.4.1 Europe Human Rabies Immunoglobulin (IM) Sales by Country
3.4.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Rabies Immunoglobulin (IM) Market Facts & Figures by Region
3.5.1 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region
3.5.2 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
3.6.1 Latin America Human Rabies Immunoglobulin (IM) Sales by Country
3.6.2 Latin America Human Rabies Immunoglobulin (IM) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country
3.7.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Rabies Immunoglobulin (IM) Historic Market Analysis by Type
4.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2021)
4.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2021)
4.3 Global Human Rabies Immunoglobulin (IM) Price by Type (2016-2021)
5 Global Human Rabies Immunoglobulin (IM) Historic Market Analysis by Application
5.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2021)
5.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2016-2021)
5.3 Global Human Rabies Immunoglobulin (IM) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Grifols Human Rabies Immunoglobulin (IM) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Human Rabies Immunoglobulin (IM) Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sichuan Yuanda Shuyang
6.4.1 Sichuan Yuanda Shuyang Corporation Information
6.4.2 Sichuan Yuanda Shuyang Description and Business Overview
6.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolio
6.4.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.5 CNBG
6.5.1 CNBG Corporation Information
6.5.2 CNBG Description and Business Overview
6.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 CNBG Human Rabies Immunoglobulin (IM) Product Portfolio
6.5.5 CNBG Recent Developments/Updates
6.6 Kamada
6.6.1 Kamada Corporation Information
6.6.2 Kamada Description and Business Overview
6.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Kamada Human Rabies Immunoglobulin (IM) Product Portfolio
6.6.5 Kamada Recent Developments/Updates
6.7 CBPO
6.6.1 CBPO Corporation Information
6.6.2 CBPO Description and Business Overview
6.6.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CBPO Human Rabies Immunoglobulin (IM) Product Portfolio
6.7.5 CBPO Recent Developments/Updates
6.8 Shuanglin Bio
6.8.1 Shuanglin Bio Corporation Information
6.8.2 Shuanglin Bio Description and Business Overview
6.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolio
6.8.5 Shuanglin Bio Recent Developments/Updates
6.9 Weiguang Bio
6.9.1 Weiguang Bio Corporation Information
6.9.2 Weiguang Bio Description and Business Overview
6.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolio
6.9.5 Weiguang Bio Recent Developments/Updates
6.10 Shanghai RAAS
6.10.1 Shanghai RAAS Corporation Information
6.10.2 Shanghai RAAS Description and Business Overview
6.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolio
6.10.5 Shanghai RAAS Recent Developments/Updates
6.11 Bharat Serum
6.11.1 Bharat Serum Corporation Information
6.11.2 Bharat Serum Human Rabies Immunoglobulin (IM) Description and Business Overview
6.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolio
6.11.5 Bharat Serum Recent Developments/Updates
6.12 VINS
6.12.1 VINS Corporation Information
6.12.2 VINS Human Rabies Immunoglobulin (IM) Description and Business Overview
6.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 VINS Human Rabies Immunoglobulin (IM) Product Portfolio
6.12.5 VINS Recent Developments/Updates
7 Human Rabies Immunoglobulin (IM) Manufacturing Cost Analysis
7.1 Human Rabies Immunoglobulin (IM) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
7.4 Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Rabies Immunoglobulin (IM) Distributors List
8.3 Human Rabies Immunoglobulin (IM) Customers
9 Human Rabies Immunoglobulin (IM) Market Dynamics
9.1 Human Rabies Immunoglobulin (IM) Industry Trends
9.2 Human Rabies Immunoglobulin (IM) Growth Drivers
9.3 Human Rabies Immunoglobulin (IM) Market Challenges
9.4 Human Rabies Immunoglobulin (IM) Market Restraints
10 Global Market Forecast
10.1 Human Rabies Immunoglobulin (IM) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Rabies Immunoglobulin (IM) by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Human Rabies Immunoglobulin (IM) by Type (2022-2029)
10.2 Human Rabies Immunoglobulin (IM) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Rabies Immunoglobulin (IM) by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Human Rabies Immunoglobulin (IM) by Application (2022-2029)
10.3 Human Rabies Immunoglobulin (IM) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Rabies Immunoglobulin (IM) by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Human Rabies Immunoglobulin (IM) by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Comparison by Application (2021-2029)
Table 3. Global Human Rabies Immunoglobulin (IM) Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Human Rabies Immunoglobulin (IM) Covered in This Study
Table 5. Global Human Rabies Immunoglobulin (IM) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Human Rabies Immunoglobulin (IM) Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Human Rabies Immunoglobulin (IM) Manufacturing Sites and Area Served
Table 11. Manufacturers Human Rabies Immunoglobulin (IM) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Human Rabies Immunoglobulin (IM) Sales by Region (2016-2021) & (K Units)
Table 16. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2016-2021)
Table 17. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Human Rabies Immunoglobulin (IM) Sales by Country (2016-2021) & (K Units)
Table 19. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2016-2021)
Table 20. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2016-2021)
Table 22. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2016-2021)
Table 24. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2016-2021)
Table 32. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2016-2021)
Table 38. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2016-2021)
Table 39. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2021)
Table 40. Global Human Rabies Immunoglobulin (IM) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2016-2021)
Table 42. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Type (2016-2021)
Table 43. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2016-2021)
Table 44. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2021)
Table 45. Global Human Rabies Immunoglobulin (IM) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2016-2021)
Table 47. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Application (2016-2021)
Table 48. CSL Behring Corporation Information
Table 49. CSL Behring Description and Business Overview
Table 50. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. CSL Behring Human Rabies Immunoglobulin (IM) Product
Table 52. CSL Behring Recent Developments/Updates
Table 53. Grifols Corporation Information
Table 54. Grifols Description and Business Overview
Table 55. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Grifols Human Rabies Immunoglobulin (IM) Product
Table 57. Grifols Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Sanofi Human Rabies Immunoglobulin (IM) Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Sichuan Yuanda Shuyang Corporation Information
Table 64. Sichuan Yuanda Shuyang Description and Business Overview
Table 65. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product
Table 67. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 68. CNBG Corporation Information
Table 69. CNBG Description and Business Overview
Table 70. CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. CNBG Human Rabies Immunoglobulin (IM) Product
Table 72. CNBG Recent Developments/Updates
Table 73. Kamada Corporation Information
Table 74. Kamada Description and Business Overview
Table 75. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Kamada Human Rabies Immunoglobulin (IM) Product
Table 77. Kamada Recent Developments/Updates
Table 78. CBPO Corporation Information
Table 79. CBPO Description and Business Overview
Table 80. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. CBPO Human Rabies Immunoglobulin (IM) Product
Table 82. CBPO Recent Developments/Updates
Table 83. Shuanglin Bio Corporation Information
Table 84. Shuanglin Bio Description and Business Overview
Table 85. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product
Table 87. Shuanglin Bio Recent Developments/Updates
Table 88. Weiguang Bio Corporation Information
Table 89. Weiguang Bio Description and Business Overview
Table 90. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Weiguang Bio Human Rabies Immunoglobulin (IM) Product
Table 92. Weiguang Bio Recent Developments/Updates
Table 93. Shanghai RAAS Corporation Information
Table 94. Shanghai RAAS Description and Business Overview
Table 95. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product
Table 97. Shanghai RAAS Recent Developments/Updates
Table 98. Bharat Serum Corporation Information
Table 99. Bharat Serum Description and Business Overview
Table 100. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Bharat Serum Human Rabies Immunoglobulin (IM) Product
Table 102. Bharat Serum Recent Developments/Updates
Table 103. VINS Corporation Information
Table 104. VINS Description and Business Overview
Table 105. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. VINS Human Rabies Immunoglobulin (IM) Product
Table 107. VINS Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Human Rabies Immunoglobulin (IM) Distributors List
Table 111. Human Rabies Immunoglobulin (IM) Customers List
Table 112. Human Rabies Immunoglobulin (IM) Market Trends
Table 113. Human Rabies Immunoglobulin (IM) Growth Drivers
Table 114. Human Rabies Immunoglobulin (IM) Market Challenges
Table 115. Human Rabies Immunoglobulin (IM) Market Restraints
Table 116. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2022-2029) & (K Units)
Table 117. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Type (2022-2029)
Table 118. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 119. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Type (2022-2029)
Table 120. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2022-2029) & (K Units)
Table 121. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Application (2022-2029)
Table 122. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 123. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Application (2022-2029)
Table 124. Global Human Rabies Immunoglobulin (IM) Sales Forecast by Region (2022-2029) & (K Units)
Table 125. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Region (2022-2029)
Table 126. Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 127. Global Human Rabies Immunoglobulin (IM) Revenue Market Share Forecast by Region (2022-2029)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Rabies Immunoglobulin (IM)
Figure 2. Global Human Rabies Immunoglobulin (IM) Market Share by Type in 2020 & 2029
Figure 3. ERIG Product Picture
Figure 4. HRIG Product Picture
Figure 5. Global Human Rabies Immunoglobulin (IM) Market Share by Application in 2020 & 2029
Figure 6. Category II Exposure
Figure 7. Category III Exposure
Figure 8. Global Human Rabies Immunoglobulin (IM) Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 9. Global Human Rabies Immunoglobulin (IM) Market Size 2016-2029 (US$ Million)
Figure 10. Global Human Rabies Immunoglobulin (IM) Sales 2016-2029 (K Units)
Figure 11. Global Human Rabies Immunoglobulin (IM) Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 12. Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers in 2020
Figure 13. Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Human Rabies Immunoglobulin (IM) Players: Market Share by Revenue in 2020
Figure 15. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2016-2021)
Figure 17. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region in 2020
Figure 18. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2016-2021)
Figure 19. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region in 2020
Figure 20. U.S. Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Human Rabies Immunoglobulin (IM) by Type (2016-2021)
Figure 45. Sales Market Share of Human Rabies Immunoglobulin (IM) by Application (2016-2021)
Figure 46. Sales Market Share of Human Rabies Immunoglobulin (IM) by Application in 2020
Figure 47. Revenue Share of Human Rabies Immunoglobulin (IM) by Application (2016-2021)
Figure 48. Revenue Share of Human Rabies Immunoglobulin (IM) by Application in 2020
Figure 49. Manufacturing Cost Structure of Human Rabies Immunoglobulin (IM)
Figure 50. Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Figure 51. Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
